UK markets closed
  • FTSE 100

    7,019.53
    +36.03 (+0.52%)
     
  • FTSE 250

    22,522.18
    +50.14 (+0.22%)
     
  • AIM

    1,254.25
    +6.12 (+0.49%)
     
  • GBP/EUR

    1.1538
    +0.0027 (+0.23%)
     
  • GBP/USD

    1.3821
    +0.0036 (+0.26%)
     
  • BTC-GBP

    44,777.76
    -878.10 (-1.92%)
     
  • CMC Crypto 200

    1,390.70
    -1.01 (-0.07%)
     
  • S&P 500

    4,177.57
    +7.15 (+0.17%)
     
  • DOW

    34,121.40
    +85.41 (+0.25%)
     
  • CRUDE OIL

    63.13
    -0.33 (-0.52%)
     
  • GOLD FUTURES

    1,777.80
    +11.00 (+0.62%)
     
  • NIKKEI 225

    29,683.37
    +40.68 (+0.14%)
     
  • HANG SENG

    28,969.71
    +176.57 (+0.61%)
     
  • DAX

    15,459.75
    +204.42 (+1.34%)
     
  • CAC 40

    6,287.07
    +52.93 (+0.85%)
     

AstraZeneca's head of R&D for oncology dies at 61

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
  • Oops!
    Something went wrong.
    Please try again later.

(Reuters) - AstraZeneca Plc's head of oncology research, Jose Baselga, has died at the age of 61, the company said on Sunday.

"An outstanding scientific leader, José leaves a lasting legacy in the scientific community and here at AstraZeneca," the company's Chief Executive Officer Pascal Soriot said https://bit.ly/3lye6YU in a statement.

The statement did not give a cause of death but Spanish newspaper La Vanguardia said Baselga had died of Creutzfeldt-Jakob disease, a rare brain condition.

Baselga joined AstraZeneca in 2019. He previously worked as Memorial Sloan Kettering Cancer Center's chief medical officer. He had also been chief of hematology/oncology at the Massachusetts General Hospital Cancer Center and a professor at Harvard Medical School.

(Reporting by Radhika Anilkumar in Bengaluru; Editing by Frances Kerry)